Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to COMBINATION THERAPY

Dana-Farber Cancer Institute

Dana-Farber Study Finds Up-front Chemotherapy Boost Could Benefit Patients with Non-Small Cell Lung Cancer

Oncology, Medical September 25th 2023

The New England Journal of Medicine

Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations

Oncology, Medical September 25th 2023

MDLinx

A Combination of Cancer Inhibitors Shows Success in Slowing Tumor Growth

Oncology, Medical September 19th 2023

Roswell Park

Roswell Park Clinical Trials Add Beta Blocker to Arsenal Against Esophageal Cancer

Oncology, Medical September 19th 2023

Renal & Urology News

Intensified Neoadjuvant Therapy Improves Outcomes in Very High-Risk Prostate Cancer

Oncology, Medical September 19th 2023

OBR Oncology

Osimertinib Plus Chemo Now First-Line Standard in EGFR-Mutated NSCLC?

Oncology, Medical September 19th 2023

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form